We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Cancer cells generally showed weak to moderate nuclear and cytoplasmic positivity. Most cases of urothelial, testicular, gastric and renal cancers were negative.
Cancer cells mainly displayed weak to moderate cytoplasmic staining with occasional additional nuclear positivity. Gliomas, skin and renal cancers were mainly negative.
GENE INFORMATION
Gene name
RPS6KA3 (HGNC Symbol)
Synonyms
CLS, HU-3, MRX19, RSK, RSK2
Description
Ribosomal protein S6 kinase, 90kDa, polypeptide 3 (HGNC Symbol)
Entrez gene summary
This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin-Lowry syndrome (CLS). [provided by RefSeq, Jul 2008]
P51812 [Direct mapping] Ribosomal protein S6 kinase alpha-3
Show all
Enzymes ENZYME proteins Transferases Kinases AGC Ser/Thr protein kinases MEMSAT-SVM predicted membrane proteins SPOCTOPUS predicted membrane proteins THUMBUP predicted membrane proteins Predicted intracellular proteins Cancer-related genes Candidate cancer biomarkers Disease related genes Potential drug targets Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)